RU93057733A - Method of stereoelective preparation of substituted piperidines - Google Patents

Method of stereoelective preparation of substituted piperidines


Publication number
RU93057733A RU93057733/04A RU93057733A RU93057733A RU 93057733 A RU93057733 A RU 93057733A RU 93057733/04 A RU93057733/04 A RU 93057733/04A RU 93057733 A RU93057733 A RU 93057733A RU 93057733 A RU93057733 A RU 93057733A
Prior art keywords
substituted piperidines
Prior art date
Application number
Other languages
Russian (ru)
Other versions
RU2105001C1 (en
Джей Роузен Терри
Original Assignee
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US67524491A priority Critical
Priority to US675.244 priority
Priority to US675244 priority
Application filed by Пфайзер Инк. filed Critical Пфайзер Инк.
Priority to PCT/US1992/000065 priority patent/WO1992017449A1/en
Publication of RU93057733A publication Critical patent/RU93057733A/en
Application granted granted Critical
Publication of RU2105001C1 publication Critical patent/RU2105001C1/en


Claims (1)

  1. New stereoselective methods for producing substituted piperidine derivatives have been proposed.
RU93057733/04A 1991-03-26 1992-01-14 Method of synthesis of substituted 3-aminopiperidine RU2105001C1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US67524491A true 1991-03-26 1991-03-26
US675.244 1991-03-26
US675244 1991-03-26
PCT/US1992/000065 WO1992017449A1 (en) 1991-03-26 1992-01-14 Stereoselective preparation of substituted piperidines

Publications (2)

Publication Number Publication Date
RU93057733A true RU93057733A (en) 1996-06-20
RU2105001C1 RU2105001C1 (en) 1998-02-20



Family Applications (1)

Application Number Title Priority Date Filing Date
RU93057733/04A RU2105001C1 (en) 1991-03-26 1992-01-14 Method of synthesis of substituted 3-aminopiperidine

Country Status (25)

Country Link
US (1) US5686615A (en)
EP (1) EP0581777A1 (en)
JP (1) JPH0794440B2 (en)
KR (1) KR0145432B1 (en)
CN (1) CN1038932C (en)
AU (1) AU647592B2 (en)
BR (1) BR9205807A (en)
CA (1) CA2106200C (en)
CZ (3) CZ293955B6 (en)
EG (1) EG19976A (en)
FI (1) FI106199B (en)
HU (1) HUT67276A (en)
IE (1) IE920939A1 (en)
IL (2) IL101328A (en)
MX (1) MX9201315A (en)
NO (1) NO180484C (en)
NZ (1) NZ242116A (en)
PL (1) PL169993B1 (en)
PT (1) PT100282A (en)
RU (1) RU2105001C1 (en)
SK (2) SK284565B6 (en)
TW (1) TW213900B (en)
WO (1) WO1992017449A1 (en)
YU (1) YU48260B (en)
ZA (1) ZA9202164B (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282203B6 (en) * 1991-06-20 2001-12-03 Pfizer Inc. Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles, their preparation method, intermediates and preparation thereof, use and pharmaceutical agent
PT533280E (en) 1991-09-20 2001-01-31 Glaxo Group Ltd New medical uses for tachykinine antagonists
US5364943A (en) * 1991-11-27 1994-11-15 Pfizer Inc. Preparation of substituted piperidines
ES2164657T3 (en) * 1992-05-18 2002-03-01 Pfizer Aza-bridged bicyclic derivatives as substance P antagonists.
JPH07506379A (en) * 1992-08-04 1995-07-13
WO1994004496A1 (en) * 1992-08-19 1994-03-03 Pfizer Inc. Substituted benzylamino nitrogen containing non-aromatic heterocycles
CA2150123C (en) * 1992-12-10 2004-12-07 Harry R. Howard Aminomethylene substituted non-aromatic heterocycles
US6369074B1 (en) * 1992-12-10 2002-04-09 Pfizer Inc. Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists
US5340826A (en) * 1993-02-04 1994-08-23 Pfizer Inc. Pharmaceutical agents for treatment of urinary incontinence
GB9305718D0 (en) 1993-03-19 1993-05-05 Glaxo Group Ltd Medicaments
US5294744A (en) * 1993-04-20 1994-03-15 Pfizer Inc. Formylation process for aromatic aldehydes
EP0700384B1 (en) * 1993-05-28 1997-07-16 Pfizer Inc. Process for preparing and resolving 2-phenyl-3-aminopiperidine
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
EP0653208A3 (en) * 1993-11-17 1995-10-11 Pfizer Pharmaceutical agents for treatment or prevention of sunburn.
EP0659409A3 (en) * 1993-11-23 1995-08-09 Pfizer Substance 1 antagonists for the inhibition of angiogenesis.
EP0655246A1 (en) * 1993-11-30 1995-05-31 Pfizer Inc. Substance P antagonists for the treatment of disorders caused by helicobacter pylori or other spiral urease-positive gram-negative bacteria
FR2728166B1 (en) 1994-12-19 1997-02-07
FR2728165B1 (en) 1994-12-19 1997-02-07
FR2728169B1 (en) 1994-12-19 1997-02-07
JP3992733B2 (en) * 1995-03-27 2007-10-17 久光製薬株式会社 Piperidine derivatives
TW340842B (en) * 1995-08-24 1998-09-21 Pfizer Substituted benzylaminopiperidine compounds
US6329396B1 (en) 1996-06-10 2001-12-11 Pfizer Inc. Substituted benzylaminopiperidine compounds
FR2741262B1 (en) 1995-11-20 1999-03-05 Oreal Use of a TNF-alpha antagonist for the treatment of skin redness of neurogenic origin
DE69623580D1 (en) * 1995-12-21 2002-10-17 Pfizer 3 - ((5-substituted benzyl) amino) -2-phenylpiperidines as Substance P antagonists
AU744261B2 (en) * 1997-04-24 2002-02-21 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating eating disorders
GB9716457D0 (en) * 1997-08-04 1997-10-08 Merck Sharp & Dohme Therapeutic agents
GB9716463D0 (en) * 1997-08-04 1997-10-08 Merck Sharp & Dohme Therapeutic agents
CA2298779A1 (en) * 1997-08-04 1999-02-18 Nadia Melanie Rupniak Use of nk-1 receptor antagonists for treating aggressive behaviour disorders
CA2298777A1 (en) * 1997-08-04 1999-02-18 Merck Sharp & Dohme Limited Use of nk-1 receptor antagonists for treating mania
GB9816897D0 (en) * 1998-08-04 1998-09-30 Merck Sharp & Dohme Therapeutic use
RS49964B (en) 1999-05-17 2008-09-29 Pfizer Products Inc., Process for preparing 2-phenyl-3-aminopyridine,substituted phenyl derivatives thereof,and salts thereof
EP1095939B1 (en) * 1999-10-18 2004-01-07 Pfizer Products Inc. Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
CA2389306C (en) 1999-11-03 2010-03-30 Albany Molecular Research, Inc. Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
IL142810D0 (en) * 2000-05-03 2002-03-10 Pfizer Prod Inc Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
BR0112350A (en) 2000-07-11 2003-06-24 Albany Molecular Res Inc The compound, pharmaceutical composition and method of treating an animal afflicted by a neurological or psychological disorder
US7067535B2 (en) * 2000-09-26 2006-06-27 Tanabe Seiyaku Co., Ltd. 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis
AU9232001A (en) * 2000-10-02 2002-04-15 Tanabe Seiyaku Co Benzylamine compound, process for producing the same, and intermediate therefor
US6911544B2 (en) 2002-10-23 2005-06-28 Pfizer Inc. Process for the preparation of (S,S)-cis-2-phenyl-3-aminopiperidine
BRPI0511183A (en) * 2004-05-21 2007-12-04 Pfizer Prod Inc (+) - (2s, 3s) -3- (2-methoxy-5-trifluoromethoxybenzylamino) -2-phenylpiperidine metabolites
MX2007000428A (en) 2004-07-15 2008-03-05 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin.
WO2006123182A2 (en) 2005-05-17 2006-11-23 Merck Sharp & Dohme Limited Cyclohexyl sulphones for treatment of cancer
KR101269568B1 (en) * 2005-07-04 2013-06-04 자난 사이텍 컴퍼니 리미티드 Ruthenium complex ligand, ruthenium complex, carried ruthenium complex catalyst and the preparing methods and the use thereof
CN101495184A (en) 2005-07-15 2009-07-29 Amr科技公司;布里斯托尔-迈尔斯斯奎布公司 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
WO2007015588A1 (en) * 2005-08-04 2007-02-08 Takeda Pharmaceutical Company Limited Piperidine derivative as tachykinin receptor antagonist
WO2007041052A2 (en) 2005-09-29 2007-04-12 Merck & Co., Inc. Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
AU2007300627B2 (en) 2006-09-22 2012-02-16 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
SI2805945T1 (en) 2007-01-10 2019-09-30 Msd Italia S.R.L. Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
US8093268B2 (en) 2007-01-24 2012-01-10 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
US8106086B2 (en) 2007-04-02 2012-01-31 Msd K.K. Indoledione derivative
JP5501227B2 (en) 2007-06-27 2014-05-21 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 4-Carboxybenzylamino derivatives as histone deacetylase inhibitors
AU2009222122A1 (en) 2008-03-03 2009-09-11 Tiger Pharmatech Tyrosine kinase inhibitors
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
AR071997A1 (en) 2008-06-04 2010-07-28 Squibb Bristol Myers Co Crystalline form of 6 - ((4S) -2-methyl-4- (2-naphthyl) -1,2,3,4-tetrahydroisoquinolin-7-yl) pyridazin-3-amine
EP2413932A4 (en) 2009-04-01 2012-09-19 Merck Sharp & Dohme Inhibitors of akt activity
EP2429296B1 (en) 2009-05-12 2017-12-27 Albany Molecular Research, Inc. 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
JP2012526823A (en) 2009-05-12 2012-11-01 アルバニー モレキュラー リサーチ, インコーポレイテッド Aryl, heteroaryl, and heterocyclic substituted tetrahydroisoquinolines and uses thereof
AU2010247735B2 (en) 2009-05-12 2015-07-16 Albany Molecular Research, Inc. Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)- 1,2,3,4-tetrahydroisoquinoline and use thereof
EA023838B1 (en) 2009-10-14 2016-07-29 Мерк Шарп Энд Домэ Корп. SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF
WO2011163330A1 (en) 2010-06-24 2011-12-29 Merck Sharp & Dohme Corp. Novel heterocyclic compounds as erk inhibitors
CN107090456A (en) 2010-08-02 2017-08-25 瑟纳治疗公司 The connection albumen led using the mediated rnai of short interfering nucleic acid(Cadherin related protein matter), the suppression of the gene expressions of β 1
EP2608669B1 (en) 2010-08-23 2016-06-22 Merck Sharp & Dohme Corp. NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
WO2012030685A2 (en) 2010-09-01 2012-03-08 Schering Corporation Indazole derivatives useful as erk inhibitors
WO2012036997A1 (en) 2010-09-16 2012-03-22 Schering Corporation Fused pyrazole derivatives as novel erk inhibitors
DK2632472T3 (en) 2010-10-29 2018-03-19 Sirna Therapeutics Inc Rna interference-mediated inhibition of gene expression using short interferring nucleic acids (sina)
WO2012087772A1 (en) 2010-12-21 2012-06-28 Schering Corporation Indazole derivatives useful as erk inhibitors
CA2833009A1 (en) 2011-04-21 2012-10-26 Merck Sharp & Dohme Corp. Insulin-like growth factor-1 receptor inhibitors
EP2770987B1 (en) 2011-10-27 2018-04-04 Merck Sharp & Dohme Corp. Novel compounds that are erk inhibitors
US20150299696A1 (en) 2012-05-02 2015-10-22 Sirna Therapeutics, Inc. SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
AU2013323508B2 (en) 2012-09-28 2017-11-02 Merck Sharp & Dohme Corp. Novel compounds that are ERK inhibitors
MX363243B (en) 2012-11-28 2019-03-14 Merck Sharp & Dohme Compositions and methods for treating cancer.
KR20150095899A (en) 2012-12-20 2015-08-21 머크 샤프 앤드 돔 코포레이션 Substituted imidazopyridines as hdm2 inhibitors
US9540377B2 (en) 2013-01-30 2017-01-10 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as HDM2 inhibitors
CN103204768A (en) * 2013-03-12 2013-07-17 西北大学 Synthetic method for hydroxybenzaldehyde
EP3041938A1 (en) 2013-09-03 2016-07-13 Moderna Therapeutics, Inc. Circular polynucleotides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2355659A (en) * 1939-12-15 1944-08-15 Hoffmann La Roche Piperidine derivatives and process for the manufacture of the same
US4267318A (en) * 1979-09-12 1981-05-12 G. D. Searle & Co. 1-(Diarylmethyl)-4-piperidinamine and derivatives thereof
MX18467A (en) * 1988-11-23 1993-07-01 Pfizer Therapeutic agents quinuclidines
WO1991009844A1 (en) * 1990-01-04 1991-07-11 Pfizer Inc. Substance p antagonists
AU648558B2 (en) * 1990-05-31 1994-04-28 Pfizer Inc. Preparation of substituted piperidines

Similar Documents

Publication Publication Date Title
DK1302549T3 (en) Method of distinguishing between sequence variants
GB2259837B (en) Method of raising fish
PL294736A1 (en) Method of obtaining novel heterocyclic derivatives
LV10614A (en) Derivative of 2-anilinopyrimidine
PT1004581E (en) Process for the preparation of thalidomide
PL164651B1 (en) Method of obtaining diarylacetylenes
PL167568B1 (en) Method of obtaining novel derivatives of quinuclidine
ZA9202164B (en) Stereoselective preparation of substituted piperidines.
HUT64110A (en) Method for producing form-body of cellulose base
RU92016535A (en) Method of obtaining omeprazol
RU93052153A (en) Method of purpose
PT1327446E (en) Oxicodone compositions of controlled libertacao
PL164204B1 (en) Method of obtaining novel derivatives of 3-aminopiperidine
PL168329B1 (en) Method of obtaining novel derivatives of dihydroisoquinoline
RU93058574A (en) Electrolizer and method for producing salt
RU94028109A (en) New substituted salicyl acids, method of their receiving
PT98638A (en) Method for the preparation of borsoline derivatives
LV10262A (en) Method of Obtaining Pharmaceutical Compounds
PL171921B1 (en) Method of obtaining novel derivatives of substituted 3-aminoquinuclidine
PL293387A1 (en) Method of obtaining benzimidazoles
PL173303B1 (en) Method of obtaining novel heterocyclic compounds
PL171766B1 (en) Method of obtaining imidazo-condensed iso- ane heterocyclic compounds
PL295891A1 (en) Method of obtaining novel derivatives of taxole
PL169085B1 (en) Method of obtaining novel derivatives of 3-amidopyrazole
PL295030A1 (en) Method of obtaining substituted derivatives of 2-cyclohexan-1-yl amine